報價延遲最少15分鐘:2024/10/31 23:14 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.125 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.43/-0.93
|
|
企業價值
34.17M
|
| 資產負債 |
|
每股賬面淨值
5.85
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.01
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/10/31 23:14 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes. |